These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8974087

  • 21. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T, Nakayama N, Ohura M, Ikezono K, Kinoshita S, Kamata M, Hosokawa T, Yamashita S, Yabuuchi Y.
    Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
    [Abstract] [Full Text] [Related]

  • 22. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
    Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K.
    Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
    [Abstract] [Full Text] [Related]

  • 23. Effects of Ca2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine.
    Masumiya H, Tanaka H, Shigenobu K.
    Eur J Pharmacol; 1997 Sep 17; 335(1):15-21. PubMed ID: 9371541
    [Abstract] [Full Text] [Related]

  • 24. Effect of nisoldipine on coronary resistance, contractility and oxygen consumption of the isolated blood-perfused canine left ventricle.
    Schipke JD, Burkhoff D, Alexander J, Schaefer J, Sagawa K.
    J Pharmacol Exp Ther; 1988 Mar 17; 244(3):1000-4. PubMed ID: 3252017
    [Abstract] [Full Text] [Related]

  • 25. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
    Fujiwara K, Kanno Y, Hayashi K, Takenaka T, Saruta T.
    Clin Exp Hypertens; 1998 Apr 17; 20(3):295-312. PubMed ID: 9605384
    [Abstract] [Full Text] [Related]

  • 26. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
    Sakanashi M, Noguchi K, Kato T, Sunagawa R, Nagamine F, Nakasone J.
    Arzneimittelforschung; 1986 Dec 17; 36(12):1736-9. PubMed ID: 3566835
    [Abstract] [Full Text] [Related]

  • 27. Effects of nisoldipine on coronary collateral perfusion and hemodynamics in chronically instrumented dogs.
    Kenny D, Hartman JC, Brooks HL, Warltier DC.
    Pharmacology; 1989 Dec 17; 38(4):263-71. PubMed ID: 2755966
    [Abstract] [Full Text] [Related]

  • 28. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
    Morimoto S, Jo F, Maki K, Iwasaka T.
    Clin Exp Hypertens; 2009 Feb 17; 31(1):83-91. PubMed ID: 19172462
    [Abstract] [Full Text] [Related]

  • 29. Effects of efonidipine hydrochloride (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats.
    Yotsumoto T, Masuda Y, Shudo C, Sugita H, Yamashita T, Tanaka S.
    Gen Pharmacol; 1995 Mar 17; 26(2):333-7. PubMed ID: 7590083
    [Abstract] [Full Text] [Related]

  • 30. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
    Tanaka H, Shigenobu K.
    Cardiovasc Drug Rev; 2002 Mar 17; 20(1):81-92. PubMed ID: 12070536
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T, Heusch G.
    Cardiology; 1997 Mar 17; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W, Shibasaki K, Asano M.
    J Cardiovasc Pharmacol; 1992 Jan 17; 19(1):60-8. PubMed ID: 1375689
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cardiovascular effects of a new dihydropyridine calcium antagonist.
    Kimura Y, Fukui H, Tanaka M, Okamoto M, Miura A, Kimura K, Enomoto H.
    Arzneimittelforschung; 1986 Sep 17; 36(9):1336-44. PubMed ID: 3790183
    [Abstract] [Full Text] [Related]

  • 38. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
    Jolly SR, Hardman HF, Gross GJ.
    J Pharmacol Exp Ther; 1981 Apr 17; 217(1):20-5. PubMed ID: 7205654
    [Abstract] [Full Text] [Related]

  • 39. Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
    Ikeda K, Saito T, Tojo K.
    Tohoku J Exp Med; 2011 Aug 17; 224(4):263-71. PubMed ID: 21757861
    [Abstract] [Full Text] [Related]

  • 40. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
    Okayama S, Imagawa K, Naya N, Iwama H, Somekawa S, Kawata H, Horii M, Nakajima T, Uemura S, Saito Y.
    Hypertens Res; 2006 Jul 17; 29(7):493-7. PubMed ID: 17044661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.